Skip to main content

The Myopathies

  • Chapter
  • First Online:
  • 1333 Accesses

Abstract

The myopathies are non-dystrophic conditions in which the muscle does not function properly. This chapter focuses on some common adult-onset myopathies, including myofibrillar myopathy, distal myopathy, and metabolic myopathy. Myofibrillar myopathies present with slowly progressive muscle weakness of distal greater than proximal muscles. The distal myopathies are a heterogeneous group of disorders that predominantly affect the distal muscles. The metabolic myopathies are a heterogeneous group of inherited conditions with exercise intolerance and rhabdomyolysis leading to progressive muscle weakness, chronic pain, and fatigue.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Selcen, D. (2011). Myofibrillar myopathies. Neuromuscular Disorders, 21(3), 161–171.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Selcen, D., Ohno, K., & Engel, A. G. (2004). Myofibrillar myopathy: Clinical, morphological and genetic studies in 63 patients. Brain, 127(Pt 2), 439–451.

    Article  PubMed  Google Scholar 

  3. Vattemi, G., Neri, M., Piffer, S., Vicart, P., Gualandi, F., Marini, M., et al. (2011). Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy. Acta Myologica, 30(2), 121–126.

    PubMed Central  PubMed  Google Scholar 

  4. Selcen, D., & Engel, A. G. (2012). Myofibrillar myopathy. In: R. A. Pagon, M. P. Adam, T. D. Bird, C. R. Dolan, C. T. Fong, K. Stephens (Eds.) GeneReviews™ [Internet]. Seattle, WA: University of Washington, Seattle; 1993–2013. 2005 January 28 [updated 2012 October 29]

    Google Scholar 

  5. Griggs, R., Vihola, A., Hackman, P., Talvinen, K., Haravuori, H., Faulkner, G., et al. (2007). Zaspopathy in a large classic late-onset distal myopathy family. Brain, 130(Pt 6), 1477–1484.

    Article  PubMed  Google Scholar 

  6. Joshi, P. R., Glaser, D., Dreßel, C., Kress, W., Weis, J., & Deschauer, M. (2014). Anoctamin 5 muscular dystrophy associated with a silent p.Leu115Leu mutation resulting in exon skipping. Neuromuscular Disorders, 24(1), 43–47.

    Article  PubMed  Google Scholar 

  7. Peterle, E., Fanin, M., Semplicini, C., Padilla, J. J., Nigro, V., & Angelini, C. (2013). Clinical phenotype, muscle MRI and muscle pathology of LGMD1F. Journal of Neurology, 260(8), 2033–2041.

    Article  PubMed  Google Scholar 

  8. Sarkozy, A., Deschauer, M., Carlier, R. Y., Schrank, B., Seeger, J., Walter, M. C., et al. (2012). Muscle MRI findings in limb girdle muscular dystrophy type 2L. Neuromuscular Disorders, 22(Suppl 2), S122–S129.

    Article  PubMed  Google Scholar 

  9. Laing, N. G. (2012). Genetics of neuromuscular disorders. Critical Reviews in Clinical Laboratory Sciences, 49(2), 33–48.

    Article  PubMed  Google Scholar 

  10. Udd, B. (2012). Distal myopathies—new genetic entities expand diagnostic challenge. Neuromuscular Disorders, 22(1), 5–12.

    Article  PubMed  Google Scholar 

  11. Kraya, T., & Zierz, S. (2013). Distal myopathies: From clinical classification to molecular understanding. Journal of Neural Transmission, 120(Suppl 1), S3–S7.

    Article  PubMed  Google Scholar 

  12. Hackman, P., Sarparanta, J., Lehtinen, S., Vihola, A., Evila, A., Jonson, P. H., et al. (2013). Welander distal myopathy is caused by a mutation in the RNA-binding protein TIA1. Annals of Neurology, 73, 500–509.

    Article  PubMed  Google Scholar 

  13. D’Amico, A., & Bertini, E. (2013). Metabolic neuropathies and myopathies. Handbook of Clinical Neurology, 113, 1437–1455.

    Article  PubMed  Google Scholar 

  14. Das, A. M., Steuerwald, U., & Illsinger, S. (2010). Inborn errors of energy metabolism associated with myopathies. Journal of Biomedicine and Biotechnology, 2010, 340849.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Selcen, D., & Engel, A. G. (2011). Myofibrillar myopathies. Handb Clin Neurol, 101, 143–154.

    Article  PubMed  Google Scholar 

  16. Gargiulo, M., Herson, A., Michon, C. C., Hogrel, J. Y., Doppler, V., Laloui, K., et al. (2013). Attitudes and expectations of patients with neuromuscular diseases about their participation in a clinical trial. Revue Neurologique (Paris), 169(8–9), 670–676.

    Article  Google Scholar 

  17. DiMauro, S., & Spiegel, R. (2011). Progress and problems in muscle glycogenoses. Acta Myologica, 30(2), 96–102.

    PubMed Central  PubMed  Google Scholar 

  18. Miteff, F., Potter, H. C., Allen, J., Teoh, H., Roxburgh, R., & Hutchinson, D. O. (2011). Clinical and laboratory features of patients with myophosphorylase deficiency (McArdle disease). Journal of Clinical Neuroscience, 18(8), 1055–1058.

    Article  PubMed  Google Scholar 

  19. Teener, J. W. (2012). Late-onset Pompe’s disease. Seminars in Neurology, 32(5), 506–551.

    PubMed  Google Scholar 

  20. Pascual, J. M., & Roe, C. R. (2013). Systemic metabolic abnormalities in adult-onset acid maltase deficiency: Beyond muscle glycogen accumulation. JAMA Neurology, 70(6), 756–763.

    Article  PubMed  Google Scholar 

  21. Bennett, M. J. (2010). Pathophysiology of fatty acid oxidation disorders. Journal of Inherited Metabolic Disease, 33(5), 533–537.

    Article  PubMed  Google Scholar 

  22. Kurt, B., Gulcan Kurt, Y., & Akgul, E. O. (2013). Importance of muscle biopsy in diagnosis of muscle diseases. Biochemical and Biophysical Research Communications, 435(4), 513.

    Article  PubMed  Google Scholar 

  23. Stumpf, J. D., Saneto, R. P., & Copeland, W. C. (2013). Clinical and molecular features of POLG-related mitochondrial disease. Cold Spring Harbor Perspectives in Biology, 5(4), a011395.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Joline Dalton .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dalton, J., Goldman, J.S., Sampson, J.B. (2015). The Myopathies. In: Goldman, J. (eds) Genetic Counseling for Adult Neurogenetic Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7482-2_19

Download citation

Publish with us

Policies and ethics